Crisaborole ointment, 2% (Eucrisa, Pfizer) has been approved for use in pediatric patients with atopic dermatitis as young as 3 months of age.
Phase 3 clinical data demonstrate abrocitinib’s efficacy and safety in treating moderate-to-severe atopic dermatitis in adults.
Originally approved in 1995 for use in adults only.
First new treatment of its kind in over 20 years.
An itchy post-shingles complication can be challenging to control.
Skin problems often require complex (and expensive) drugs, so how can you help?
Apricus Biosciences and its wholly owned subsidiary, NexMed USA, have received FDA approval for over-the-counter sales of antifungal drug Tolnaftate-D, containing the company's NexACT technology, which transiently loosens the tight junction between the cells of the sealed skin to allow more permeation.
FDA announced new testing and labeling requirements for OTC sunscreen products that will help manufacturers better indicate those that when used with other sun protection measures reduce the risk of skin cancer and early skin aging, as well as help prevent sunburn, according to a news release issued by the agency.
Rite Aid kicked off the summer by launching a new healthy skin care campaign in partnership with the Skin Cancer Foundation. The program includes free consumer information in all Rite Aid stores and online as well as increased professional information for the chain?s pharmacists.
Summer's outdoor fun can be complicated by poison ivy, bug bites, harsh sunlight, and other problems exacerbated by the heat and humidity. A variety of products seek to prevent or ameliorate the consequences.